These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 24896364)
61. Erythropoietin-mediated protection of insect brain neurons involves JAK and STAT but not PI3K transduction pathways. Miljus N; Heibeck S; Jarrar M; Micke M; Ostrowski D; Ehrenreich H; Heinrich R Neuroscience; 2014 Jan; 258():218-27. PubMed ID: 24269933 [TBL] [Abstract][Full Text] [Related]
62. Nonsteroidal anti-inflammatory drugs in clinical and experimental epilepsy. Radu BM; Epureanu FB; Radu M; Fabene PF; Bertini G Epilepsy Res; 2017 Mar; 131():15-27. PubMed ID: 28212985 [TBL] [Abstract][Full Text] [Related]
63. Erythropoietin: a hormone with multiple functions. Lombardero M; Kovacs K; Scheithauer BW Pathobiology; 2011; 78(1):41-53. PubMed ID: 21474975 [TBL] [Abstract][Full Text] [Related]
64. Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy. Hernández C; Simó R Endocrine; 2012 Apr; 41(2):220-6. PubMed ID: 22167324 [TBL] [Abstract][Full Text] [Related]
65. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Iwai M; Cao G; Yin W; Stetler RA; Liu J; Chen J Stroke; 2007 Oct; 38(10):2795-803. PubMed ID: 17702962 [TBL] [Abstract][Full Text] [Related]
66. Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders. Kang YJ; Digicaylioglu M; Russo R; Kaul M; Achim CL; Fletcher L; Masliah E; Lipton SA Ann Neurol; 2010 Sep; 68(3):342-52. PubMed ID: 20818790 [TBL] [Abstract][Full Text] [Related]
67. The Promises and Challenges of Erythropoietin for Treatment of Alzheimer's Disease. Sun J; Martin JM; Vanderpoel V; Sumbria RK Neuromolecular Med; 2019 Mar; 21(1):12-24. PubMed ID: 30656553 [TBL] [Abstract][Full Text] [Related]
68. Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases. Merelli A; Czornyj L; Lazarowski A Int J Neurosci; 2015; 125(11):793-7. PubMed ID: 25405533 [TBL] [Abstract][Full Text] [Related]
69. Erythropoietin Ameliorates Neonatal Hypoxia-Ischemia-Induced Neurobehavioral Deficits, Neuroinflammation, and Hippocampal Injury in the Juvenile Rat. Lan KM; Tien LT; Cai Z; Lin S; Pang Y; Tanaka S; Rhodes PG; Bhatt AJ; Savich RD; Fan LW Int J Mol Sci; 2016 Feb; 17(3):289. PubMed ID: 26927081 [TBL] [Abstract][Full Text] [Related]
70. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Brines ML; Ghezzi P; Keenan S; Agnello D; de Lanerolle NC; Cerami C; Itri LM; Cerami A Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10526-31. PubMed ID: 10984541 [TBL] [Abstract][Full Text] [Related]
72. The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. Hasselblatt M; Ehrenreich H; Sirén AL J Neurosurg Anesthesiol; 2006 Apr; 18(2):132-8. PubMed ID: 16628067 [TBL] [Abstract][Full Text] [Related]
73. Erythropoietin in the brain: can the promise to protect be fulfilled? Maiese K; Li F; Chong ZZ Trends Pharmacol Sci; 2004 Nov; 25(11):577-83. PubMed ID: 15491780 [TBL] [Abstract][Full Text] [Related]